NEW YORK, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), Dollar General Corporation (NYSE: DG), and The Clorox Company (NYSE: CLX). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Orthofix Medical Inc. (NASDAQ: OFIX)

On September 12, 2023, before the market opened, Orthofix disclosed that its Board's independent directors made the unanimous decision to terminate for cause Keith Valentine, John Bostjancic and Patrick Keran from their roles as Chief Executive Officer, Chief Financial Officer, and Chief Legal Officer, respectively. The Board also requested that Mr. Valentine resign from the Board. The Company further disclosed that the decision followed an investigation conducted by independent outside legal counsel and directed and overseen by the Company's independent directors, and that the Board determined that each of the executives engaged in conduct that "violated multiple code of conduct requirements and was inconsistent with the Company's values and culture."

On this news, Orthofix's share price fell $5.62, or 30.2%, to close at $13.01 per share on September 12, 2023, thereby injuring investors.

For more information on the Orthofix investigation go to: https://bespc.com/cases/OFIX

Dollar General Corporation (NYSE: DG)

On June 1, 2023, Dollar announced lower than expected results for the first quarter 2023. Further, the Company cut its guidance by almost 10% for the full year 2023 blaming it on “a function of the macroenvironment.” Analysts commenting on the Company’s missed guidance referenced its recent pricing shifts.

Following this news, Dollar’s stock price fell by $39.23 per share, or approximately 20% to close at $161.86 per share.

For more information on the Dollar investigation go to: https://bespc.com/cases/DG

The Clorox Company (NYSE: CLX)

On August 14, 2023, Clorox disclosed that it had "identified unauthorized activity on some of its Information Technology (IT) systems" and that "the incident has caused, and is expected to continue to cause, disruption to parts of [Clorox]'s business operations." On this news, Clorox's stock price fell $2.56 per share, or 1.6%, to close at $157.61 per share on August 15, 2023. Then, on September 18, 2023, Clorox further revealed that, after the cybersecurity attack, Clorox "implemented its business continuity plans and began manual ordering and processing procedures shortly . . . at a reduced rate of operations" and that Clorox was "operating at a lower rate of order processing and has recently begun to experience an elevated level of consumer product availability issues." Clorox also disclosed that "[d]ue to the order processing delays and elevated level of product outages, [Clorox] now believes the impact will be material on Q1 financial results."

On this news, Clorox's stock price fell $3.50 per share, or 2.39%, to close at $142.70 per share on September 18, 2023.

For more information on the Clorox investigation go to: https://bespc.com/cases/CLX

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com